UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries (TOF/PA/MAPCAs)

Authors
Ritu Asija, MD
Stanton Perry, MD
Section Editors
David R Fulton, MD
Candice Silversides, MD, MS, FRCPC
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

Tetralogy of Fallot with pulmonary valve atresia and major aortopulmonary collateral arteries (TOF/PA/MAPCAs) is the most extreme variant of TOF, in which complete atresia of the pulmonary valve replaces pulmonary stenosis.

The definition, anatomy, physiology, clinical presentation, management, and outcome of TOF/PA/MAPCAs will be reviewed here.

INCIDENCE

TOF/PA is relatively rare, with a reported incidence of 0.7 per 10,000 live births in the Baltimore-Washington Infant Study [1]. While TOF is the most common cyanotic congenital heart lesion, TOF/PA/MAPCAs is considered to be the most extreme form of TOF and accounts for approximately one-fifth of all cases of TOF [2].

ANATOMY

TOF/PA is a complex lesion that includes characteristic features of TOF (anterior malaligned ventricular septal defect [VSD] and overriding aorta) with PA. PA may be limited to the valve itself (membranous PA) or involve the subpulmonary infundibulum (muscular PA), and results in no antegrade flow from the right ventricle (RV) to the pulmonary artery. (See "Pulmonary atresia with intact ventricular septum (PA/IVS)", section on 'Pulmonary valve atresia'.)

The lack of antegrade pulmonary blood flow in utero leads to a range of morphologic findings in the pulmonary artery vasculature. If the ductus arteriosus (DA) is present, confluent true pulmonary arteries of variable size may develop. Without flow through the DA, MAPCAs, fetal vessels derived from the splanchnic vascular plexus, may persist after birth [3]. These vessels connect the systemic and pulmonary arterial vasculature, thereby supplying pulmonary blood flow. MAPCAs are tortuous vessels that arise directly from the aorta or its branches. MAPCAs vary in number and origin, follow circuitous routes to reach central, lobar, and segmental pulmonary arteries, and have variable areas and locations of stenosis. Their arborization pattern is unpredictable and often incomplete, leaving some lung segments with excessive or insufficient flow, and they can become narrow over time [4,5]. As a result, a given segment of the lung may be supplied solely from the true pulmonary arteries, solely from the MAPCAs, or both. The morphology of the pulmonary vasculature and MAPCAs plays a critical role in determining management decisions. (See 'Surgical intervention' below.)

                             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Feb 11 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Malformations of the Cardiac Outflow Tract in Genetic and Environmental Risk Factors of Major Cardiovascular Malformations. In: The Baltimore-Washington Infant Study 1981-1989, Ferencz C LC, Correa-Villasenor A, et al (Eds), Futura Publishing, Armonk 1997.
  2. O'Leary PW, Edwards, William D, et al. Moss and Adams' Heart Disease in Infants, Children and Adolescents, Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (Eds), Lippincott Williams & Wilkins, Philadelphia 2008.
  3. Liao PK, Edwards WD, Julsrud PR, et al. Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect. J Am Coll Cardiol 1985; 6:1343.
  4. Hanley FL. MAPCAs, bronchials, monkeys, and men. Eur J Cardiothorac Surg 2006; 29:643.
  5. Rabinovitch M, Herrera-deLeon V, Castaneda AR, Reid L. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation 1981; 64:1234.
  6. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation 2002; 106:1374.
  7. Silversides CK, Lionel AC, Costain G, et al. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet 2012; 8:e1002843.
  8. Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32:492.
  9. Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 2010; 105:1617.
  10. Carotti A, Albanese SB, Filippelli S, et al. Determinants of outcome after surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2010; 140:1092.
  11. van Engelen K, Topf A, Keavney BD, et al. 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart 2010; 96:621.
  12. Tansatit M, Kongruttanachok N, Kongnak W, et al. Tetralogy of Fallot with absent pulmonary valve in a de novo derivative chromosome 9 with duplication of 9p13 --> 9pter and deletion of 9q34.3. Am J Med Genet A 2006; 140:1981.
  13. Yamamoto T, Dowa Y, Ueda H, et al. Tetralogy of Fallot associated with pulmonary atresia and major aortopulmonary collateral arteries in a patient with interstitial deletion of 16q21-q22.1. Am J Med Genet A 2008; 146A:1575.
  14. Seale AN, Ho SY, Shinebourne EA, Carvalho JS. Prenatal identification of the pulmonary arterial supply in tetralogy of Fallot with pulmonary atresia. Cardiol Young 2009; 19:185.
  15. Malhotra SP, Hanley FL. Surgical management of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: a protocol-based approach. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009; :145.
  16. Geva T, Greil GF, Marshall AC, et al. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation 2002; 106:473.
  17. Lin MT, Wang JK, Chen YS, et al. Detection of pulmonary arterial morphology in tetralogy of Fallot with pulmonary atresia by computed tomography: 12 years of experience. Eur J Pediatr 2012; 171:579.
  18. Kirklin JW, Blackstone EH, Kirklin JK, et al. Surgical results and protocols in the spectrum of tetralogy of Fallot. Ann Surg 1983; 198:251.
  19. Reddy VM, Petrossian E, McElhinney DB, et al. One-stage complete unifocalization in infants: when should the ventricular septal defect be closed? J Thorac Cardiovasc Surg 1997; 113:858.
  20. Mainwaring RD, Reddy VM, Perry SB, et al. Late outcomes in patients undergoing aortopulmonary window for pulmonary atresia/stenosis and major aortopulmonary collaterals. Ann Thorac Surg 2012; 94:842.
  21. Schulze-Neick I, Ho SY, Bush A, et al. Severe airflow limitation after the unifocalization procedure: clinical and morphological correlates. Circulation 2000; 102:III142.
  22. Maskatia SA, Feinstein JA, Newman B, et al. Pulmonary reperfusion injury after the unifocalization procedure for tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2012; 144:184.
  23. Asija R, Hanley FL, Roth SJ. Postoperative respiratory failure in children with tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collaterals: a pilot study. Pediatr Crit Care Med 2013; 14:384.
  24. Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J Am Coll Cardiol 1995; 25:491.
  25. Wernovsky G, Rome JJ, Tabbutt S, et al. Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis 2006; 1:10.
  26. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31:2915.
  27. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008; 118:2395.
  28. Veldtman GR, Connolly HM, Grogan M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004; 44:174.